Market Cap 36.79M
Revenue (ttm) 16.89M
Net Income (ttm) -37.80M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -223.80%
Debt to Equity Ratio 0.00
Volume 74,500
Avg Vol 171,340
Day's Range N/A - N/A
Shares Out 14.66M
Stochastic %K 27%
Beta -0.80
Analysts Strong Sell
Price Target $16.33

Company Profile

Veru Inc., a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and viral-induced acute respiratory distress syndrome (ARDS). Its marketed products comprise FC2 female condom for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections. The company's development program includes enobosarm, a selective androgen receptor modulator for treatment of augment fat loss and to preven...

Industry: Biotechnology
Sector: Healthcare
Phone: 305 509 6897
Address:
2916 North Miami Avenue, Suite 1000, Miami, United States
_SquidGains_
_SquidGains_ Nov. 13 at 11:40 PM
0 · Reply
Ljkjr
Ljkjr Nov. 13 at 5:35 PM
$VERU Pfizer plans to enter GLP-1 space by 2028, CEO explains https://finance.yahoo.com/video/pfizer-plans-enter-glp-1-165814799.html
1 · Reply
_ReddBullyz
_ReddBullyz Nov. 12 at 4:24 PM
Gotta give it to @Invinc1ble dude’s been on a hot streak 🔥 Worth a follow! $HIND $NAOV $WATT $VERU Viewing;
0 · Reply
mrkymrk
mrkymrk Nov. 11 at 10:30 PM
$VERU I guess no earnings call. Just a black box of incompetence
0 · Reply
Eesnimi
Eesnimi Nov. 11 at 7:51 AM
$VERU Any ideas for $30 average bag holder?
1 · Reply
mrkymrk
mrkymrk Nov. 10 at 3:09 PM
$VERU anyone know the status of the offering? These clowns never write me back so I don’t bother anymore.
1 · Reply
PennyConnection1
PennyConnection1 Nov. 6 at 5:51 PM
$VERU under .25 cents pre split
0 · Reply
mrkymrk
mrkymrk Nov. 6 at 4:23 PM
$VERU trump making deals to lower GLP-1 drugs should make drug companies want to pursue a cheaper oral option even more aggressively. It’s also easier to ship, store and preferred by patients. It’s a small molecule drug that can be combined in a a fixed dose with a GLP. This is an absolute slam dunk and VERU management can’t get a deal done!!! Market cap is now only $40M!! THEY ALL NEED FIRED!!!!!!!!!
0 · Reply
mrkymrk
mrkymrk Nov. 6 at 2:54 PM
$VERU and yet non of these “executives” will buy shares with their “own” money. In parentheses because their salaries are paid by capital raise only.
0 · Reply
mrkymrk
mrkymrk Nov. 6 at 2:52 PM
$VERU still hasn’t closed out the offering. These idiots should all be fired. They can’t give their shares away.
0 · Reply
Latest News on VERU
Veru to Present Two Abstracts at ObesityWeek 2025

Oct 31, 2025, 8:30 AM EDT - 14 days ago

Veru to Present Two Abstracts at ObesityWeek 2025


Veru Announces Proposed Public Offering

Oct 29, 2025, 4:01 PM EDT - 16 days ago

Veru Announces Proposed Public Offering


Veru Inc. (VERU) Q3 2025 Earnings Call Transcript

Aug 12, 2025, 12:57 PM EDT - 3 months ago

Veru Inc. (VERU) Q3 2025 Earnings Call Transcript


Veru Announces Reverse Stock Split

Aug 6, 2025, 8:30 AM EDT - 3 months ago

Veru Announces Reverse Stock Split


Veru to Participate in the 2025 BTIG Virtual Biotech Conference

Jul 22, 2025, 8:30 AM EDT - 4 months ago

Veru to Participate in the 2025 BTIG Virtual Biotech Conference


Veru to Participate in the Virtual BTIG Obesity Health Forum

Jun 11, 2025, 8:30 AM EDT - 5 months ago

Veru to Participate in the Virtual BTIG Obesity Health Forum


Veru's Enobosarm Shows Muscle In Wegovy Combo Trial

May 28, 2025, 12:11 PM EDT - 6 months ago

Veru's Enobosarm Shows Muscle In Wegovy Combo Trial


Veru: Saving Muscle Mass Amidst The GLP-1 Drug Boom

May 26, 2025, 9:36 PM EDT - 6 months ago

Veru: Saving Muscle Mass Amidst The GLP-1 Drug Boom


Veru Inc. (VERU) Q2 2025 Earnings Call Transcript

May 8, 2025, 12:42 PM EDT - 6 months ago

Veru Inc. (VERU) Q2 2025 Earnings Call Transcript


Veru Participates in a Virtual Investor KOL Connect Segment

May 8, 2025, 9:25 AM EDT - 6 months ago

Veru Participates in a Virtual Investor KOL Connect Segment


Veru Inc (VERU) Q1 2025 Earnings Call Transcript

Feb 13, 2025, 2:35 PM EST - 9 months ago

Veru Inc (VERU) Q1 2025 Earnings Call Transcript


Veru Inc. (VERU) Q3 2024 Earnings Call Transcript

Aug 10, 2024, 8:39 AM EDT - 1 year ago

Veru Inc. (VERU) Q3 2024 Earnings Call Transcript


Veru to Present at the Jefferies Global Healthcare Conference

May 22, 2024, 8:30 AM EDT - 1 year ago

Veru to Present at the Jefferies Global Healthcare Conference


Veru Announces Steven B. Heymsfield M.D.

May 15, 2024, 8:30 AM EDT - 1 year ago

Veru Announces Steven B. Heymsfield M.D.


Veru to Present at the GLP-1 Based Therapeutics Summit

May 2, 2024, 8:30 AM EDT - 1 year ago

Veru to Present at the GLP-1 Based Therapeutics Summit


Veru Reschedules Annual Meeting of Shareholders

Mar 22, 2024, 4:05 PM EDT - 1 year ago

Veru Reschedules Annual Meeting of Shareholders


_SquidGains_
_SquidGains_ Nov. 13 at 11:40 PM
0 · Reply
Ljkjr
Ljkjr Nov. 13 at 5:35 PM
$VERU Pfizer plans to enter GLP-1 space by 2028, CEO explains https://finance.yahoo.com/video/pfizer-plans-enter-glp-1-165814799.html
1 · Reply
_ReddBullyz
_ReddBullyz Nov. 12 at 4:24 PM
Gotta give it to @Invinc1ble dude’s been on a hot streak 🔥 Worth a follow! $HIND $NAOV $WATT $VERU Viewing;
0 · Reply
mrkymrk
mrkymrk Nov. 11 at 10:30 PM
$VERU I guess no earnings call. Just a black box of incompetence
0 · Reply
Eesnimi
Eesnimi Nov. 11 at 7:51 AM
$VERU Any ideas for $30 average bag holder?
1 · Reply
mrkymrk
mrkymrk Nov. 10 at 3:09 PM
$VERU anyone know the status of the offering? These clowns never write me back so I don’t bother anymore.
1 · Reply
PennyConnection1
PennyConnection1 Nov. 6 at 5:51 PM
$VERU under .25 cents pre split
0 · Reply
mrkymrk
mrkymrk Nov. 6 at 4:23 PM
$VERU trump making deals to lower GLP-1 drugs should make drug companies want to pursue a cheaper oral option even more aggressively. It’s also easier to ship, store and preferred by patients. It’s a small molecule drug that can be combined in a a fixed dose with a GLP. This is an absolute slam dunk and VERU management can’t get a deal done!!! Market cap is now only $40M!! THEY ALL NEED FIRED!!!!!!!!!
0 · Reply
mrkymrk
mrkymrk Nov. 6 at 2:54 PM
$VERU and yet non of these “executives” will buy shares with their “own” money. In parentheses because their salaries are paid by capital raise only.
0 · Reply
mrkymrk
mrkymrk Nov. 6 at 2:52 PM
$VERU still hasn’t closed out the offering. These idiots should all be fired. They can’t give their shares away.
0 · Reply
QAZx666
QAZx666 Nov. 6 at 5:42 AM
$VERU A final prospectus supplement related to the offering will be filed with the SEC, and will be available on the website of the SEC at http://www.sec.gov. Copies of the final prospectus supplement and the accompanying prospectus relating to this offering may also be obtained when available by contacting Canaccord Genuity LLC, Attention: Syndication Department, One Post Office Square, Suite 3000, Boston, Massachusetts 02109, or by telephone at (617) 371-3900, or by email at [email protected]; or Oppenheimer & Co. Inc., Attention: Syndicate Prospectus Department, 85 Broad Street, 26th Floor, New York, NY 10004, or by telephone at (212) 667-8055, or by email at [email protected].
0 · Reply
QAZx666
QAZx666 Nov. 5 at 7:47 PM
$VERU Until this deal is finalized and the smoke clears the price of Veru shares will probably be suppressed, but the ceiling on price should be lifted when this new financing is in place and the company can go back to taking care of business and not spending so much effort on finding the cash to keep going.
1 · Reply
QAZx666
QAZx666 Nov. 5 at 7:39 PM
$VERU Canaccord Genuity LLC and Oppenheimer & Co. Inc. . . . . . These are in my opinion both respected investment firms. Oppenheimer & Co particularly is a big name outfit that has never had to beg for business or compromise their standards to get business. Canaccord Genuity LLC is, as far as I know, a smaller, but respected, quality firm that does a lot of north of the border (Canada) deals. To get both of them willing to share the books is not a small achievement for Veru and Steiner. Canaccord particularly reminds me of Allen and Co., a firm that always wanted to grab the best small deals. And raising $25 million with more coming if that next Enobosarm Phase achieves its goal is impressive. I will bet both firms looked this deal over pretty closely before signing on as underwriters.
0 · Reply
Truthseeker7856
Truthseeker7856 Nov. 5 at 5:14 PM
$VERU Why is the share price fluctuating between $2.55/ share and $39.01/ share? Glitch
1 · Reply
mrkymrk
mrkymrk Nov. 5 at 2:45 PM
$VERU they expected to close their offering last Friday. They still haven’t raised enough money to fund the trials. No idea on where they stand with warrants. That’s why stock continues to fall as they flood the market with unwanted shares. These guys are the fucking worst management ever and don’t deserve even 10% of what they make. It’s absolutely criminal and they should be embarrassed.
0 · Reply
WallStreetBuyDip
WallStreetBuyDip Nov. 5 at 11:11 AM
How do you trade small and mid cap stocks? I buy when H% is low. Nothing else. I keep track of my results to see if my strategy worked out or not. $BBIG + $VERU will trade the same.
0 · Reply
BioRich
BioRich Nov. 4 at 4:54 PM
$ALT Just so there's no confusion for the $ALT PermaPumpers pushing $ALT discontinued (dead) Obesity Program, they are not listed as participating in the upcoming "Innovation in Obesity Therapeutics Summit", San Diego December 2-4, 2025. Several others of interest are including $VERU, who will highlight their excellent collaborations for damn near immaculate lean mass preservation. If folks are interested in actual science of the sector, I suggest you look at $VERU and you'll quickly realize why no one cared about $ALT. Cheers!
0 · Reply
TradeHuntFish
TradeHuntFish Nov. 4 at 3:50 PM
VEEE could flip from quiet to viral fast. Latest news upgrade + bottomed structure + low borrow = classic breakout ingredients. If the daily golden cross forms and momentum shifts, this is the kind of micro‑cap that moves 3× to 5× in short order. $CVKD $SLNO $DRCT $VERU
0 · Reply
QAZx666
QAZx666 Nov. 4 at 1:15 PM
$VERU This deal has not been well received by many of our shareholders, but here is my opinion. If Veru would have gotten a deal with a well financed major drug company we would have been lucky to have walked away with 3%-5% royality, if that. And no guarantees as to how much the buyout company would spend on research. We would basicly be out of the world of drug development. And no cash in our pockets. I am thinking that Dr. Steiner did a good job of keeping us on the playing field. The amount of new shares and warrants etc that have been issued and and can be issued under certain circumstances does dilute our interests, but we in no way took a 3%-5% haircut. As it stands we have seen Dr. Steiner go to the market place and dig up some cash when no one on this board thought that was even possible. I predict that our shares will find higher ground as the market digests what has taken place these last few weeks. We had an interest in a lottery ticket, now we have a part interest.
0 · Reply
jimmy167
jimmy167 Nov. 4 at 12:53 PM
$VERU $GUTS $TNXP is @BioRich still talking nonsense here? Please stay away from anything that guy says he's all hot air. Do your own research and don't rely on some guy you've never met to guide your investments.
2 · Reply
gicu
gicu Nov. 4 at 9:48 AM
0 · Reply
TradeHuntFish
TradeHuntFish Nov. 4 at 4:16 AM
VEEE could flip from quiet to viral fast. Latest news upgrade + bottomed structure + low borrow = classic breakout ingredients. If the daily golden cross forms and momentum shifts, this is the kind of micro‑cap that moves 3× to 5× in short order. $CVKD $SLNO $DRCT $VERU
0 · Reply